22157.jpg
Global Vaccine Contract Manufacturing Market, 2021-2025: Cumulative Impact of COVID-19 - Paradigm Shift Toward Cell-Based Vaccine Production
February 17, 2021 05:33 ET | Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing Market Research Report by Function (Downstream and Upstream), by Type (Attenuated Vaccine, DNA Vaccines, Inactivated...
22157.jpg
Expert Quantitative Analysis on the COVID-19 Contract Vaccine Manufacturing Industry
January 07, 2021 11:58 ET | Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape" report has been added to ResearchAndMarkets.com's...
Develop manufacturing process for polio
Batavia Biosciences receives $6.5M grant to take next step towards polio-free world
September 16, 2019 07:00 ET | Batavia Biosciences B.V.
Leiden, the Netherlands, Sep 16, 2019 – Today, Batavia Biosciences announces it received a grant of $6.5 million from the Bill & Melinda Gates Foundation to develop a manufacturing process for a...
Batavia Biosciences - PATH collaboration polio vaccines
Batavia Biosciences receives $2.2 million follow-up grant from PATH to support new tools for polio eradication era
July 08, 2019 07:00 ET | Batavia Biosciences B.V.
Leiden, 4 Jul 2019 – Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop and manufacture novel...
Batavia Biosciences process development viral vector-based Nipah vaccine
Batavia Biosciences partners with the University of Tokyo to develop a vector-based vaccine against Nipah virus
May 14, 2019 07:00 ET | Batavia Biosciences B.V.
Leiden, the Netherlands, May 14, 2019 – Batavia Biosciences announced today that it will work together in a consortium including the European Vaccine Initiative and Stanford University, icddr,b, and...
Highly intensified IPV production process
Batavia Biosciences Receives $13.2M Grant to Accelerate Market Access of Low-Cost Inactivated Polio Vaccine
February 25, 2019 05:00 ET | Batavia Biosciences B.V.
Leiden, The Netherlands, February 25, 2019 – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade...